Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

636 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response.
Mashima H, Zhang R, Kobayashi T, Hagiya Y, Tsukamoto H, Liu T, Iwama T, Yamamoto M, Lin C, Nakatsuka R, Mishima Y, Watanabe N, Yamada T, Senju S, Kaneko S, Idiris A, Nakatsura T, Ohdan H, Uemura Y. Mashima H, et al. Among authors: iwama t. Oncoimmunology. 2020 Sep 6;9(1):1814620. doi: 10.1080/2162402X.2020.1814620. Oncoimmunology. 2020. PMID: 33457097 Free PMC article.
Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy.
Mashima H, Zhang R, Kobayashi T, Tsukamoto H, Liu T, Iwama T, Hagiya Y, Yamamoto M, Fukushima S, Okada S, Idiris A, Kaneko S, Nakatsura T, Ohdan H, Uemura Y. Mashima H, et al. Among authors: iwama t. Mol Ther Methods Clin Dev. 2021 Mar 5;21:171-179. doi: 10.1016/j.omtm.2021.03.002. eCollection 2021 Jun 11. Mol Ther Methods Clin Dev. 2021. PMID: 33816647 Free PMC article.
Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice.
Iwama T, Uchida T, Sawada Y, Tsuchiya N, Sugai S, Fujinami N, Shimomura M, Yoshikawa T, Zhang R, Uemura Y, Nakatsura T. Iwama T, et al. Biochem Biophys Res Commun. 2016 Jan 1;469(1):138-143. doi: 10.1016/j.bbrc.2015.11.084. Epub 2015 Nov 23. Biochem Biophys Res Commun. 2016. PMID: 26616051 Free article.
Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells.
Tsuchiya N, Zhang R, Iwama T, Ueda N, Liu T, Tatsumi M, Sasaki Y, Shimoda R, Osako Y, Sawada Y, Kubo Y, Miyashita A, Fukushima S, Cheng Z, Nakaki R, Takubo K, Okada S, Kaneko S, Ihn H, Kaisho T, Nishimura Y, Senju S, Endo I, Nakatsura T, Uemura Y. Tsuchiya N, et al. Among authors: iwama t. Cell Rep. 2019 Oct 1;29(1):162-175.e9. doi: 10.1016/j.celrep.2019.08.086. Cell Rep. 2019. PMID: 31577946 Free article.
Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells.
Kitayama S, Zhang R, Liu TY, Ueda N, Iriguchi S, Yasui Y, Kawai Y, Tatsumi M, Hirai N, Mizoro Y, Iwama T, Watanabe A, Nakanishi M, Kuzushima K, Uemura Y, Kaneko S. Kitayama S, et al. Among authors: iwama t. Stem Cell Reports. 2016 Feb 9;6(2):213-27. doi: 10.1016/j.stemcr.2016.01.005. Stem Cell Reports. 2016. PMID: 26862702 Free PMC article.
Immune cell therapy against disseminated melanoma by utilizing induced pluripotent stem cell-derived myeloid cell lines producing interferon-beta or interleukin-15/interleukin-15 receptor alpha.
Mizuhashi S, Kubo Y, Fukushima S, Kanemaru H, Nakahara S, Miyasita A, Ishibashi T, Kuriyama H, Kimura T, Masuguchi S, Zhang R, Iwama T, Nakatsura T, Uemura Y, Senju S, Ihn H. Mizuhashi S, et al. Among authors: iwama t. J Dermatol Sci. 2021 May;102(2):133-136. doi: 10.1016/j.jdermsci.2021.03.005. Epub 2021 Mar 26. J Dermatol Sci. 2021. PMID: 33836927 No abstract available.
636 results